BRISTOL MYERS SQUIBB CO (BMY)

↓ Download CSV

CIK 0000014272 · NYSE · Pharmaceutical Preparations

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

In fiscal 2025, BRISTOL MYERS SQUIBB CO reported revenue of $48.19B, down 0.2% from the prior year. The company was profitable, with a net margin of 14.6%. It held $90.04B in total assets against $71.53B in total liabilities.

Key ratios (FY2025)

14.6%
Net margin
38.2%
Return on equity
-0.2%
Revenue growth (YoY)
Metric (FY)2025202420232022202120202019201820172016
Revenue$48.19B$48.30B$45.01B$46.16B$46.38B$42.52B$26.14B$22.56B$20.78B$19.43B
Cost of Revenue$13.94B$13.97B$10.69B$10.14B$9.94B$11.77B$8.08B$6.47B$6.01B$4.97B
Gross Profit$30.75B$18.07B$16.09B$14.68B$14.48B
Net Income$7.05B-$8.95B$8.03B$6.33B$6.99B-$9.02B$3.44B$4.92B$1.01B$4.46B
EPS (Diluted)$3.46$-4.41$3.86$2.95$3.12$-3.99$2.01$3.01$0.61$2.65
Total Assets$90.04B$92.60B$95.16B$96.82B$109.31B$118.48B$129.94B$34.99B$33.55B$33.71B
Total Liabilities$71.53B$76.22B$65.67B$65.70B$73.31B$80.60B$78.25B$20.86B$21.70B$17.36B
Shareholders' Equity$18.47B$16.34B$29.43B$31.06B$35.95B$37.82B$51.60B$14.03B$11.74B$16.18B
Cash & Equivalents$10.21B$10.35B$11.46B$9.12B$13.98B$14.55B$12.35B$6.91B$5.42B$4.24B
Operating Cash Flow$14.16B$15.19B$13.86B$13.07B$16.21B$14.05B$8.21B$7.07B$5.28B$3.06B
Capital Expenditures$1.31B$1.25B$1.21B$1.12B$973.00M$753.00M$836.00M$951.00M$1.05B$1.22B
Shares Outstanding2.04B2.03B2.08B2.15B2.25B2.26B1.71B1.64B1.65B1.68B
Dividends Per Share$2.49$2.42$2.31$2.19$2.01$1.84$1.68$1.61$1.57$1.53